1,423 results on '"Kaplan, Gilaad G."'
Search Results
2. Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America
3. The Cost of Inflammatory Bowel Disease Care – How to Make it Sustainable
4. Epidemiologic Burden and Projections for Eosinophilic Esophagitis–Associated Emergency Department Visits in the United States: 2009-2030
5. Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study
6. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
7. Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
8. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
9. Variation in Testing for and Incidence of Celiac Autoimmunity in Canada: A Population-Based Study
10. Multiple Sclerosis Risk Among Anti-tumor Necrosis Factor Alpha Users: A Methodological Review of Observational Studies Based on Real-world Data
11. Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn’s Disease but Not in Ulcerative Colitis
12. Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent
13. Meta-analysis of multi-jurisdictional health administrative data from distributed networks approximated individual-level multivariable regression
14. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study
15. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
16. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
17. Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
18. Prophylactic clipping to prevent delayed colonic post-polypectomy bleeding: meta-analysis of randomized and observational studies
19. Risk of Multiple Sclerosis Among Users of Antitumor Necrosis Factor Alpha in Four Canadian Provinces: A Population-Based Study
20. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials
21. When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
22. Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study.
23. Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study
24. Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study
25. An International Reporting Registry of Patients With Celiac Disease and COVID-19: Initial Results From SECURE-CELIAC
26. Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis
27. Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
28. COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
29. Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis
30. The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease
31. Hospitalization with Clostridioides difficile in pediatric inflammatory bowel disease: a population-based study
32. Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study
33. Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005–2016)
34. The four epidemiological stages in the global evolution of inflammatory bowel disease
35. Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Toward Sustaining Healthcare Delivery.
36. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century
37. Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases
38. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review
39. Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies
40. Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease
41. Eosinophilic esophagitis: seeing only the tip of the iceberg
42. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases
43. S1099 Comparison of Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Between Smokers and Non-Smokers
44. S1100 Associations Between Body Mass Index and Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
45. S1112 Incidence and Outcomes of Prostate Cancer in Patients With Inflammatory Bowel Disease: A Canadian Population-Based Study
46. S1791 Patterns in Follow-Up Testing for Individuals Newly Positive for Celiac Disease Antibodies
47. S1098 Serological Responses to SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Are Impaired for Those on Anti-TNF and Immunomodulator Combination Therapy
48. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
49. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development
50. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.